Lessee, Operating Lease, Liability, to be Paid, Year Three of Chemomab Therapeutics Ltd. from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary: Chemomab Therapeutics Ltd. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD history and change rate from 31 Dec 2019 to 31 Dec 2024.
Chemomab Therapeutics Ltd. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 31 Dec 2024 was $120,000, a 0.83% decline year-over-year.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)

Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)

Chemomab Therapeutics Ltd. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$120,000	-$1,000	-0.83%	31 Dec 2024	20-F	04 Apr 2025	2024	FY
Q4 2023	$121,000	+$28,000	+30%	31 Dec 2023	20-F	28 Mar 2024	2023	FY
Q4 2022	$93,000	-$40,000	-30%	31 Dec 2022	10-K	20 Mar 2023	2022	FY
Q4 2021	$133,000	+$117,000	+731%	31 Dec 2021	10-K	30 Mar 2022	2021	FY
Q4 2020	$16,000	-$347,000	-96%	31 Dec 2020	10-K	09 Mar 2021	2020	FY
Q4 2019	$363,000			31 Dec 2019	10-K	17 Mar 2020	2019	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.